InnerScope Hearing Technologies, Inc. INND

Company Overview

InnerScope Hearing Technologies, Inc. is a U.S.-based hearing technology and direct-to-consumer healthcare company focused on affordable hearing solutions, over-the-counter (OTC) hearing aids, hearing health products, and related distribution services. The company operates within the broader hearing healthcare, medical device, and consumer wellness industries. Its business model centers on developing, marketing, distributing, and retailing hearing-related products through e-commerce channels, retail partnerships, and hearing screening platforms. Public disclosures and market reporting identify hearing aids, hearing amplifiers, hearing screening systems, and associated accessories as key revenue drivers.

The company evolved from a hearing healthcare distribution and retail-focused operation into a broader OTC hearing technology platform aligned with regulatory changes in the U.S. hearing aid market. Following the U.S. FDA’s implementation of OTC hearing aid regulations, the company emphasized lower-cost hearing products aimed at consumers with perceived mild-to-moderate hearing loss. InnerScope has publicly positioned itself around accessibility, affordability, and retail distribution expansion, particularly through pharmacy and consumer retail channels.

Business Operations

InnerScope generates revenue primarily through the sale of hearing aids, hearing assistive products, hearing screening technologies, and related consumer hearing solutions. Its operations have included direct-to-consumer e-commerce activity, wholesale distribution, and retail placement initiatives. The company has also promoted self-service hearing screening kiosks and hearing test technologies intended for use in retail environments. Public filings and company communications reference activities involving hearing health diagnostics, branded hearing products, and consumer-focused wellness distribution.

The company’s operational footprint has been concentrated primarily in the United States, although certain products and components are sourced through international manufacturing and supply relationships common within the hearing device industry. InnerScope has disclosed strategic relationships involving retail distribution and technology deployment initiatives, though the scale and financial contribution of some partnerships have not always been fully quantified in publicly available filings. Data regarding the long-term commercial performance of certain announced initiatives is inconclusive based on available public sources.

Strategic Position & Investments

InnerScope’s strategic direction has focused on expanding access to lower-cost hearing healthcare products following the emergence of the U.S. OTC hearing aid category. The company has publicly emphasized retail expansion, digital distribution, and hearing health accessibility as central growth initiatives. Public disclosures have also referenced efforts to broaden consumer awareness through pharmacy, big-box retail, and online marketplace channels. The company has sought to differentiate itself through affordability-focused positioning and broad consumer accessibility rather than premium clinical audiology services.

The company has announced acquisitions and strategic investments intended to expand its hearing healthcare platform, including interests tied to hearing aid distribution, hearing screening systems, and consumer hearing brands. Publicly discussed initiatives have included retail hearing screening deployments and product portfolio expansion. However, publicly available information regarding the operational scale, profitability, or integration outcomes of certain acquisitions and strategic initiatives remains limited. Data inconclusive based on available public sources.

Geographic Footprint

InnerScope’s headquarters and principal market presence are in the United States, where the company focuses primarily on OTC hearing healthcare consumers and retail distribution opportunities. Its business activities have targeted national retail placement and online sales channels across multiple U.S. regions. The company’s operational strategy has centered largely on domestic hearing healthcare demand and regulatory developments tied to OTC hearing aids.

Although the company’s primary commercial focus is domestic, aspects of manufacturing, sourcing, and supply chain activity appear connected to broader international electronics and hearing device production networks. Public disclosures indicate exposure to international sourcing relationships, but detailed reporting on foreign operational infrastructure or direct overseas market penetration has been limited.

Leadership & Governance

InnerScope’s leadership has emphasized consumer accessibility, affordability, and expansion of hearing healthcare distribution channels. Corporate communications and public filings have consistently framed the company’s strategic vision around increasing access to hearing technologies through retail and direct-to-consumer channels. Governance and executive oversight are disclosed through OTC market filings and related corporate disclosures.

Key executives and leadership figures publicly associated with the company include:

• Matthew Moore – Chief Executive Officer
• Matthew Moore – Chairman
• Joseph Affrunti – Former executive leadership and strategic advisor roles referenced in public disclosures

Additional executive and governance information has appeared periodically in public filings and company announcements, though some leadership records across reporting periods are not fully consistent across all publicly accessible sources.